$NVO
Novo Nordisk
14 articles
By following, you request company-alert emails. Manage or stop them anytime in your account. Privacy.
We've curated 14 independent analyst write-ups on $NVO from newsletters and Substacks — sorted by date.
Can Novo's Perception Get Any Worse?
Novo Nordisk ($NVO) • By Rene Sellmann • 2026-10-02
$NVO: Going against the current
Novo Nordisk ($NVO) • By TQI Capital • 2026-08-12
The Peptide Fortress: A Deep Dive into Novo Nordisk’s 100-Year Head Start
Novo Nordisk ($NVO) • By CompoundingAlpha • 2026-04-06
$NVO: Novo Nordisk: When “Cheap” Isn’t Safe
Novo Nordisk ($NVO) • By TQI Capital • 2026-02-05
$Nvo: Novo Nordisk
Novo Nordisk ($NVO) • By TQI Capital • 2026-01-26
Stock of the Week: Novo Nordisk - A Possible Inflection Point, Powered by Oral Therapies
Novo Nordisk ($NVO) • By Quality Stocks • 2026-01-15
Novo Nordisk ($NVO): A Quality Investing Deep Dive into the GLP-1 Leader's Long-Term Potential and Risks
Novo Nordisk ($NVO) • By Compound & Fire • 2025-11-18
Stock of the Week - Novo Nordisk: A Fall from Grace Hiding Untapped Opportunities?
Novo Nordisk ($NVO) • By Quality Stocks • 2025-08-12
Earnings Review: AMD & Novo Nordisk
Novo Nordisk ($NVO) • By Rebound Capital • 2025-08-06
Novo Nordisk - 9 years later
Novo Nordisk ($NVO) • By Value and Opportunity • 2025-08-01
Stock of the Week: Novo Nordisk
Novo Nordisk ($NVO) • By Quality Stocks • 2025-02-13
Eli Lilly vs Novo Nordisk: a Stock Duel
Novo Nordisk ($NVO) • By Quality Stocks • 2024-10-13
Novo Nordisk, Miracle Drug Creator?
Novo Nordisk ($NVO) • By Quality Stocks • 2024-01-27